Sign In
Buy ABT
$100.79
+0.200 (+0.199%)
At Close: Jul 23, 2026
Got $5,000? These 3 High-Yielding Stocks Are Trading Near Their 52-Week Lows
08:46am, Wednesday, 06'th May 2026
These stocks pay more than double the S&P 500 average and have modest valuations relative to the overall market.
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Tuesday, 05'th May 2026
Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Polen Focus Growth Portfolio Q1 2026 Portfolio Update
11:32am, Monday, 04'th May 2026
In Q1 2026, Polen Focus Growth Portfolio returned -17.27% (net of fees) compared to -9.78% for the Index. Starbucks was the top performing absolute and relative contributor in Q1 amid positive signs t
This Dividend King's Yield Hasn't Been This High in a Decade. Is It a Buy?
08:15am, Sunday, 03'rd May 2026
Abbott Laboratories (ABT 1.47%) is offering income investors a rare setup: a yield is approaching 3% while the business continues to grow. The stock isn't a screaming bargain, and rising costs matter,
Wall Street Week Ahead
06:51am, Sunday, 03'rd May 2026
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
1 Magnificent Dividend Stock Down 30% to Buy and Hold Forever
01:30am, Saturday, 02'nd May 2026
This company, which has raised its dividend for 54 consecutive years, is on sale.
How to Pick a Healthcare Stock That Can Weather Any Market
09:45am, Tuesday, 28'th Apr 2026
Abbott Laboratories is a very diversified company, which can reduce some risks. The medical products maker is a committed dividend payer, too, with a solid yield.
Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform
09:00am, Tuesday, 28'th Apr 2026
Ultreon 3.0 is the first advanced optical coherence tomography (OCT) system in the U.S. and Europe that integrates high resolution coronary plaque images and AI-automated insights through the artery T
Comerica Bank Has $92.14 Million Stake in Abbott Laboratories $ABT
05:58am, Monday, 27'th Apr 2026
Comerica Bank trimmed its stake in shares of Abbott Laboratories (NYSE: ABT) by 3.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange
Abbott Laboratories $ABT Shares Purchased by Aprio Wealth Management LLC
04:02am, Monday, 27'th Apr 2026
Aprio Wealth Management LLC boosted its holdings in shares of Abbott Laboratories (NYSE: ABT) by 114.9% during the undefined quarter, according to its most recent 13F filing with the SEC. The fund own
Abbott Laboratories $ABT Shares Purchased by Advisors Capital Management LLC
03:15am, Sunday, 26'th Apr 2026
Advisors Capital Management LLC increased its holdings in shares of Abbott Laboratories (NYSE: ABT) by 3.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Excha
Four late-breaking presentations at Heart Rhythm Society 2026 in Chicago highlight strong clinical evidence across Abbott's growing pulsed field ablation and novel cardiac pacing portfolios Six-month
Best Dividend Kings: April 2026
08:26pm, Friday, 24'th Apr 2026
Dividend Kings are outperforming SPY year-to-date, with 36 of 58 beating the index with an average gain of 7.03% versus SPY's 4.18%. Twenty-seven Dividend Kings are both potentially undervalued and of
Brokers Suggest Investing in Abbott (ABT): Read This Before Placing a Bet
10:33am, Friday, 24'th Apr 2026
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
Abbott Laboratories: Buying A Healthcare Giant On Sale
08:20am, Friday, 24'th Apr 2026
After reaching a cycle high of $141.23 per share in early March 2025, Abbott Laboratories closed at $92.48 as of April 23rd, the equivalent of a ~35% decline in just over a year. This is now one of th
